Stocks and Investing
Stocks and Investing
Wed, June 29, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Thome Maintained (AXSM) at Buy with Increased Target to $130 on, Jun 29th, 2022
Joseph Thome of Cowen & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $120 to $130 on, Jun 29th, 2022.
Joseph has made no other calls on AXSM in the last 4 months.
There are 4 other peers that have a rating on AXSM. Out of the 4 peers that are also analyzing AXSM, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vikram Purohit of "Morgan Stanley" Maintained at Hold with Decreased Target to $27 on, Wednesday, April 27th, 2022
These are the ratings of the 3 analyists that currently disagree with Joseph
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Decreased Target to $49 on, Tuesday, May 3rd, 2022
- Chris Howerton of "Jefferies" Maintained at Strong Buy with Increased Target to $77 on, Tuesday, March 29th, 2022
- Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 2nd, 2022
Contributing Sources